Showing results (41-50 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|February 7, 2022
Toxic epidermal necrolysis associated with chemoimmunotherapy for lymphoma: case report and literature reviewWei Yang, Xiaofeng Xu, Dajing Xia, et al.Immunotherapy|October 19, 2021
Sintilimab plus sorafenib: a novel regimen for hepatocellular carcinomaXuhong Liu, Yong YiImmunotherapy|February 14, 2022
Recurrent delayed immune-related pneumonitis after immune-checkpoint inhibitor therapy for advanced osteosarcomaAhmet Küçükarda, İvo Gökmen, Erkan Özcan, et al.Immunotherapy|February 14, 2022
Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature reviewMehmet Akif Eksin, Abdulsamet Erden, Serdar Can Güven, et al.Immunotherapy|February 14, 2022
Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitorsFrancesco Serra, Irene Cassaniti, Daniele Lilleri, et al.Immunotherapy|February 14, 2022
Peptide-MHC complexes: dressing up to manipulate T cells against autoimmunity and cancerArpita Sahoo, Debangshu Mukherjee, Dhrubajyoti Mahata, et al.Immunotherapy|June 15, 2019
Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experienceSabrina Rossi, Giovanna Finocchiaro, Luca Toschi, et al.Immunotherapy|May 17, 2018
Ragweed sublingual tablet immunotherapy: part II - practical considerations and pertinent issuesOliver Pfaar, Peter Socrates CreticosImmunotherapy|November 27, 2023
The role of filgotinib in ulcerative colitis and Crohn's diseaseJacopo Fanizza, Ferdinando D'Amico, Gaetano Lauri, et al.Immunotherapy|November 8, 2023
Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry studyJohn M Kirkwood, Lisa A Kottschade, Robert R McWilliams, et al.Pageof 188